BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
221 hedge funds and large institutions have $2.73B invested in Blueprint Medicines in 2022 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 89 increasing their positions, 66 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
33% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 46
34% less capital invested
Capital invested by funds: $4.15B → $2.73B (-$1.42B)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
221
Holding in Top 10
4
Calls
$10.8M
Puts
$15.9M
Top Buyers
| 1 | +$51.7M | |
| 2 | +$26.9M | |
| 3 | +$23.2M | |
| 4 |
BlackRock
New York
|
+$22.7M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$15.5M |
Top Sellers
| 1 | -$96.2M | |
| 2 | -$47.1M | |
| 3 | -$30.4M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$21.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$18.1M |